Brief: ICL And Lavie Bio Enter Strategic Collaboration To Develop Novel Bio-Stimulant Products
16/08/2022 23:13
Aug 16 (Reuters) - Evogene Ltd EVGN.TA :
* ICL AND LAVIE BIO ENTER STRATEGIC COLLABORATION TO DEVELOP
NOVEL
BIO-STIMULANT PRODUCTS
* ICL GROUP LTD - TO INVEST $10 MILLION IN LAVIE BIO
Source text for Eikon: ID:nBw5j8m37a
Further company coverage: EVGN.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icl
See all newsBrief: Icl Group Prices Private Offering Of $800 Million Senior Notes Due 2036
Brief: ICL Group To Use Proceeds For Debt Repayment, Capital Expenditures, Investments & Acquisitions
Israeli fertiliser maker ICL beats quarterly profit estimates, raises 2026 outlook (updated)
Israel's ICL Group beats quarterly profit estimates, raises 2026 outlook as potash sales surge
Brief: Icl Announces Chief Financial Officer Transition